Investor Relations

Hyperion Therapeutics, Inc. is a commercial stage biopharmaceutical company committed to developing and delivering life-changing treatments for orphan diseases.

Stock Quote

Price / Change

46.02

0.04

Ticker:
HPTX
Exchange:
NASDAQ
Day High:
46.36
Day Low:
45.97
Volume:
195,900

4:00 PM ET on April 20, 2015
Delayed at least 20 minutes.
Provided by eSignal.